Total Payments
$7,744
2024 Payments
$361.54
Companies
34
Transactions
380
Medicare Patients
6,527
Medicare Billing
$390,648
Payment Breakdown by Category
Food & Beverage$6,988 (90.2%)
Travel$752.34 (9.7%)
Education$4.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,988 | 375 | 90.2% |
| Travel and Lodging | $752.34 | 4 | 9.7% |
| Education | $4.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,417 | 91 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,152 | 16 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $1,062 | 50 | $0 (2023) |
| Amgen Inc. | $643.63 | 32 | $0 (2024) |
| PFIZER INC. | $531.56 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $434.19 | 29 | $0 (2024) |
| Boston Scientific Corporation | $333.12 | 17 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $295.91 | 17 | $0 (2024) |
| Abbott Laboratories | $240.21 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $198.46 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $361.54 | 20 | Novartis Pharmaceuticals Corporation ($167.69) |
| 2023 | $785.18 | 43 | Novartis Pharmaceuticals Corporation ($363.93) |
| 2022 | $302.16 | 15 | Novartis Pharmaceuticals Corporation ($95.60) |
| 2021 | $710.51 | 37 | Novartis Pharmaceuticals Corporation ($239.99) |
| 2020 | $429.31 | 23 | Janssen Pharmaceuticals, Inc ($205.87) |
| 2019 | $1,280 | 71 | Janssen Pharmaceuticals, Inc ($242.52) |
| 2018 | $1,291 | 73 | Janssen Pharmaceuticals, Inc ($253.95) |
| 2017 | $2,585 | 98 | Medtronic Vascular, Inc. ($1,138) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $48.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Cardiovascular | ||||||
| 02/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology | ||||||
| 02/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/15/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Heart Failure | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/30/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,809 | 2,778 | $322,905 | $97,603 |
| 2022 | 15 | 1,520 | 2,362 | $289,474 | $88,131 |
| 2021 | 18 | 1,628 | 2,546 | $309,663 | $104,086 |
| 2020 | 19 | 1,570 | 2,308 | $304,099 | $100,828 |
Total Patients
6,527
Total Services
9,994
Medicare Billing
$390,648
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 25 | 29 | $3,654 | $1,582 | 43.3% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 36 | 66 | $5,610 | $1,409 | 25.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 19 | $3,325 | $1,089 | 32.8% |
| 93282 | Evaluation, testing and programming adjustment of defibrillator with analysis, review and report, single lead defibrillator system | Office | 2021 | 11 | 11 | $1,925 | $568.10 | 29.5% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 20 | 22 | $2,090 | $445.83 | 21.3% |
| 93272 | Heart rhythm symptom-related interpretation of 24-hour ekg monitoring up to 30 days | Office | 2021 | 12 | 12 | $1,080 | $251.28 | 23.3% |
| 93270 | Heart rhythm symptom-related tracing of 24-hour ekg monitoring up to 30 days | Office | 2021 | 13 | 13 | $1,950 | $102.70 | 5.3% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2021 | 14 | 14 | $140.00 | $33.80 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 105 | 223 | $49,283 | $19,202 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 244 | $55,144 | $19,147 | 34.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 79 | 202 | $33,936 | $12,092 | 35.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 97 | 102 | $29,172 | $11,465 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 52 | $21,788 | $8,057 | 37.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 572 | 795 | $27,825 | $5,692 | 20.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 72 | 75 | $13,125 | $4,600 | 35.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 58 | 69 | $10,695 | $3,930 | 36.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 48 | $8,400 | $2,857 | 34.0% |
| 93295 | Remote evaluations of defibrillator up to 90 days with analysis, review and report | Office | 2020 | 40 | 85 | $12,750 | $2,368 | 18.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 132 | 181 | $12,670 | $2,287 | 18.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,967 | $2,277 | 38.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 27 | $6,102 | $1,743 | 28.6% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2020 | 23 | 27 | $3,312 | $1,580 | 47.7% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2020 | 38 | 70 | $5,950 | $1,415 | 23.8% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 37 | 41 | $3,895 | $896.31 | 23.0% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2020 | 11 | 11 | $2,200 | $867.76 | 39.4% |
About Dr. Marino Leonardi, MD
Dr. Marino Leonardi, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Norristown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467461707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marino Leonardi, MD has received a total of $7,744 in payments from pharmaceutical and medical device companies, with $361.54 received in 2024. These payments were reported across 380 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,988).
As a Medicare-enrolled provider, Leonardi has provided services to 6,527 Medicare beneficiaries, totaling 9,994 services with total Medicare billing of $390,648. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Norristown, PA
- Active Since 08/05/2006
- Last Updated 01/24/2017
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1467461707
Products in Payments
- ENTRESTO (Drug) $1,342
- XARELTO (Drug) $1,130
- Micra (Device) $1,003
- ELIQUIS (Drug) $656.77
- Corlanor (Drug) $468.31
- LifeVest (Device) $295.91
- Repatha (Biological) $171.32
- PRADAXA (Drug) $169.61
- Vascepa (Drug) $160.95
- CHANTIX (Drug) $157.95
- WATCHMAN (Device) $139.91
- CardioMEMS HF System (Device) $122.84
- PRALUENT (Drug) $110.95
- PRALUENT ALIROCUMAB INJECTION (Biological) $105.77
- VYNDAQEL (Drug) $90.38
- WATCHMAN Access System (Device) $85.24
- SelectSecure (Device) $84.13
- LAA035, LAA040, LAA045, LAA050 (Device) $81.29
- LEQVIO (Drug) $74.45
- Pacemakers (Device) $71.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.